Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Teva Launches Authorized Generic Of Provigil - Quick Facts

RELATED NEWS
Trade TEVA now with 

Teva Pharmaceutical Industries Ltd. (TEVA: Quote) announced the launch of the authorized generic of Provigil (modafinil). Provigil is marketed by Cephalon, Inc., a wholly owned subsidiary of Teva.

Teva noted that Provigil will continue to be manufactured under the brand product's new drug application at the same facility where it is currently produced. Shipping of the product has begun.

As per the IMS sales data, the brand product had annual sales of around $1.1 billion in US.

Click here to receive FREE breaking news email alerts for Teva Pharmaceutical Industries Limited and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Philippine economy grew more-than-expected in the second quarter on strong support from foreign demand, figures from the National Statistical Coordination Board showed Thursday. Gross domestic product for the second quarter advanced 6.4 percent year-on-year, exceeding economists' expectation for 6.1 percent growth. This followed by a revised 5.6 percent rise seen in the first quarter. Hewlett-Packard has recalled the AC power cords for its HP and Compaq notebook computer, citing a tendency to overheat, causing a potential fire and burn hazard. HP requests that consumers stop using the cord immediately and contact them to order a replacement cord free of charge. A UN report describing terrible atrocities carried out by Islamic State militants in Syria says children as young as 10 are being recruited and trained at ISIS camps as fighters. The report, based on 480 interviews and and evidence collected between 20 January and 15 July, chronicles the unimaginable brutality and human cost of the Syrian conflict. The report by the independent international com
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.